Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study

Ruixian Xing, Apeng Yang, Juan Huang, Liang Wang, Wei Guo, Qu Cui, Xiaoqiong Tang, Yuanyuan Ma, Kai Hu, Tianheng He, Danyang Wu, Xiaofang Deng, Yajing Zhang, Kaili Zhong, Yang Liu, Yixian Guo, Ying Wang, Chan Long, Chongyang Wu, Xin Lu, Fengmin Li, Jiefei Bai, Jun Qian, Xuefei Sun, Wenrong Huang, Hui Zhou, Huilai Zhang, Ou Bai, Xiaobing Huang, Zhiyong Zeng, Lin Fu

Open source

DOI: 10.1158/2643-3230.bcd-26-0128
Published: 2026-09-11
Container: Blood Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2643-3230.bcd-26-0128,
  title = {Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study},
  author = {Ruixian Xing and Apeng Yang and Juan Huang and Liang Wang and Wei Guo and Qu Cui and Xiaoqiong Tang and Yuanyuan Ma and Kai Hu and Tianheng He and Danyang Wu and Xiaofang Deng and Yajing Zhang and Kaili Zhong and Yang Liu and Yixian Guo and Ying Wang and Chan Long and Chongyang Wu and Xin Lu and Fengmin Li and Jiefei Bai and Jun Qian and Xuefei Sun and Wenrong Huang and Hui Zhou and Huilai Zhang and Ou Bai and Xiaobing Huang and Zhiyong Zeng and Lin Fu},
  year = {2026},
  journal = {Blood Cancer Discovery},
  doi = {10.1158/2643-3230.bcd-26-0128},
  url = {https://doi.org/10.1158/2643-3230.bcd-26-0128}
}

RIS

TY  - JOUR
TI  - Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study
AU  - Ruixian Xing
AU  - Apeng Yang
AU  - Juan Huang
AU  - Liang Wang
AU  - Wei Guo
AU  - Qu Cui
AU  - Xiaoqiong Tang
AU  - Yuanyuan Ma
AU  - Kai Hu
AU  - Tianheng He
AU  - Danyang Wu
AU  - Xiaofang Deng
AU  - Yajing Zhang
AU  - Kaili Zhong
AU  - Yang Liu
AU  - Yixian Guo
AU  - Ying Wang
AU  - Chan Long
AU  - Chongyang Wu
AU  - Xin Lu
AU  - Fengmin Li
AU  - Jiefei Bai
AU  - Jun Qian
AU  - Xuefei Sun
AU  - Wenrong Huang
AU  - Hui Zhou
AU  - Huilai Zhang
AU  - Ou Bai
AU  - Xiaobing Huang
AU  - Zhiyong Zeng
AU  - Lin Fu
PY  - 2026
JO  - Blood Cancer Discovery
DO  - 10.1158/2643-3230.bcd-26-0128
UR  - https://doi.org/10.1158/2643-3230.bcd-26-0128
ER  -

APA

Xing, R., Yang, A., Huang, J., Wang, L., Guo, W., Cui, Q., Tang, X., Ma, Y., Hu, K., He, T., Wu, D., Deng, X., Zhang, Y., Zhong, K., Liu, Y., Guo, Y., Wang, Y., Long, C., Wu, C., Lu, X., Li, F., Bai, J., Qian, J., Sun, X., Huang, W., Zhou, H., Zhang, H., Bai, O., Huang, X., Zeng, Z., & Fu, L. (2026). Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-26-0128

Source records

crossref · retrieved 2026-09-26T06:57:40.883Z